Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
NCT ID:
NCT02055820
Group ID:
EG004
Title:
Venetoclax 800 mg +R-CHOP Phase II
Description:
Phase II: Participants received 6 cycles of CHOP and 8 cycles of venetoclax (at dose determined in Phase I) + rituximab. Each cycle consisted of 21 days. Participants who experienced ongoing response without excessive toxicity could receive up to eight cycles of CHOP following discussion between the investigator and the Medical Monitor.
Deaths Number Affected:
33
Deaths Number At Risk:
None
Serious Number Affected:
116
Serious Number At Risk:
208
Other Number Affected:
204
Other Number At Risk:
208
Study:
NCT02055820
Results Section:
NCT02055820
Adverse Events Module:
NCT02055820